The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Release and Activity of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 by Alveolar Macrophages from Patients with Chronic Obstructive Pulmonary Disease
Abstract
Destruction of lung elastin is critical for development of emphysema associated with chronic obstructive pulmonary disease (COPD). Lung macrophages release elastolytic enzymes, including matrix metalloproteinase (MMP)-9, along with tissue inhibitors of MMP (TIMP). We examined the production and activity of macrophage-derived MMP-9 and TIMP-1 from alveolar macrophages (AM) from smokers with COPD, healthy smokers (HS), and nonsmokers (NS). AM were stimulated with either lipopolysaccharide (LPS), interleukin (IL)-1 beta, or cigarette smoke-conditioned culture medium (CSM). AM from patients with COPD released greater amounts of MMP-9 with greater enzymatic activity than HS and NS. In contrast, AM from NS released more TIMP-1 than cells from HS and subjects with COPD. LPS and IL-1 beta caused a dose-dependent increase in MMP-9 release and activity, together with increased levels of TIMP-1. Dexamethasone prevented the increase in MMP-9 release, and increased TIMP-1 release. CSM increased MMP-9 and TIMP-1 release from AM of all groups. Dexamethasone decreased CSM-stimulated MMP-9 release, but had no effect on MMP-9 activity This study suggests that macrophages might be important in the development of COPD because these cells exhibit increased levels of elastolytic activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Higgins, S. M. F., Macken, A. P., Cullen, W., Saunders, J., Dunne, C. P., & O’Gorman, C. S. (2013) · PubMed · doi:10.34961/9953 · Cited by 4,806
Matrix metalloproteinases and their inhibitors in connective tissue remodeling
Woessner, J. F. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.8.1850705 · Cited by 3,282
The global burden of disease, 1990–2020
Lopez, A. D., & Murray, C. C. J. L. (1998) · Nature Medicine · doi:10.1038/3218 · Cited by 1,614
Free-radical chemistry of cigarette smoke and its toxicological implications.
Church, D. F., & Pryor, W. A. (1985) · Environmental Health Perspectives · doi:10.1289/ehp.8564111 · Cited by 1,441
Keatings, V. M., Collins, P. D., Scott, D. M., & Barnes, P. J. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.2.8564092 · Cited by 1,362
Self-citationOxidants in Cigarette Smoke Radicals, Hydrogen Peroxide, Peroxynitrate, and Peroxynitritea
PRYOR, W. A., & STONE, K. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb39148.x · Cited by 1,152
Rajagopalan, S., Meng, X. P., Ramasamy, S., Harrison, D. G., & Galis, Z. S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119076 · Cited by 1,141
O'Shaughnessy, T. C., Ansari, T. W., Barnes, N. C., & Jeffery, P. K. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.3.9117016 · Cited by 694
Shapiro, S. D., Endicott, S. K., Province, M. A., Pierce, J. A., & Campbell, E. J. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115204 · Cited by 644
Human 92- and 72-kilodalton type IV collagenases are elastases.
Senior, R. M., Griffin, G. L., Fliszar, C. J., Shapiro, S. D., Goldberg, G. I., & Welgus, H. G. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89530-1 · Cited by 545
Matrix metalloproteinase inhibitors
Wojtowicz-Praga, S. M., Dickson, R. B., & Hawkins, M. J. (1997) · Investigational New Drugs · doi:10.1023/a:1005722729132 · Cited by 518
Bond, M., Fabunmi, R. P., Baker, A. H., & Newby, A. C. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01034-5 · Cited by 512
Matrix Metalloproteinase Expression and Production by Alveolar Macrophages in Emphysema
FINLAY, G. A., O'DRISCOLL, L. R., RUSSELL, K. J., D'ARCY, E. M., MASTERSON, J. B., FITZGERALD, M. X., & O'CONNOR, C. M. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.1.9612018 · Cited by 440
VIGNOLA, A. M., RICCOBONO, L., MIRABELLA, A., PROFITA, M., CHANEZ, P., BELLIA, V., MAUTINO, G., D'ACCARDI, P., BOUSQUET, J., & BONSIGNORE, G. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.6.9803014 · Cited by 389
Denhardt, D. T., Feng, B., Edwards, D. R., Cocuzzi, E. T., & Malyankar, U. M. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90074-n · Cited by 269
LIM, S., ROCHE, N., OLIVER, B. G., MATTOS, W., BARNES, P. J., & FAN CHUNG, K. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.4.9910097 · Cited by 246
Self-citationNeutrophil Granule Proteins in Bronchoalveolar Lavage Fluid from Subjects with Subclinical Emphysema
BETSUYAKU, T., NISHIMURA, M., TAKEYABU, K., TANINO, M., VENGE, P., XU, S., & KAWAKAMI, Y. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.6.9809043 · Cited by 234
Shapiro, S. D. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm/150.6_pt_2.s160 · Cited by 193
Martin, T. R., Raghu, G., Maunder, R. J., & Springmeyer, S. C. (1985) · PubMed · doi:10.1164/arrd.1985.132.2.254 · Cited by 178
Cigarette smoking and health. American Thoracic Society.
(1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.2.8564146 · Cited by 176
Inactivation of tissue inhibitor of metalloproteinase‐1 by peroxynitrite
Frears, E. R., Zhang, Z., Blake, D. R., O'Connell, J. P., & Winyard, P. G. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00065-8 · Cited by 169
Chapman, H. A., Stone, O. L., & Vavrin, Z. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111275 · Cited by 166
Mason, R. J., Buist, A. S., Fisher, E. B., Merchant, J. A., Samet, J. M., & Welsh, C. (1985) · PubMed · doi:10.1164/arrd.1985.132.5.1133 · Cited by 163
Clark, S. D., Kobayashi, D. K., & Welgus, H. G. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113203 · Cited by 145
Gottlieb, D. J., Stone, P. J., Sparrow, D., Gale, M. E., Weiss, S. T., Snider, G. L., & O’Connor, G. T. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.5.8912738 · Cited by 134
Stone, P. J., Gottlieb, D. J., O’Connor, G. T., et al. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.4.7697272 · Cited by 125
STARCHER, B. C. (1986) · Thorax · doi:10.1136/thx.41.8.577 · Cited by 123
Elastin Degradation by Human Alveolar Macrophages: A Prominent Role of Metalloproteinase Activity
Senior, R. M., Connolly, N. L., Cury, J., Welgus, H. G., & Campbell, E. J. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/139.5.1251 · Cited by 119
Gibbs, D. F., Shanley, T. P., Warner, R. L., Murphy, H. S., Varani, J., & Johnson, K. J. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.20.6.3482 · Cited by 117
Jones, P. A., & Werb, Z. (1980) · The Journal of Experimental Medicine · doi:10.1084/jem.152.6.1527 · Cited by 102
Chronic obstructive pulmonary disease: new opportunities for drug development
Barnes, P. J. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(98)01245-0 · Cited by 52
Self-citation
Cited by
Chronic obstructive pulmonary disease: molecular and cellularmechanisms
Barnes, P. J., Shapiro, S. D., & Pauwels, R. A. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00040703 · Cited by 1,439
Self-citationPharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.
Czock, D., Keller, F., Rasche, F. M., & H??ussler, U. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544010-00003 · Cited by 886
Outcomes for COPD pharmacological trials: from lung function to biomarkers
Cazzola, M., MacNee, W., Martinez, F. J., Rabe, K. F., Franciosi, L. G., Barnes, P. J., Brusasco, V., Burge, P. S., Calverley, P. M. A., Celli, B. R., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00099306 · Cited by 858
Self-citationMediators of Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.2 · Cited by 710
Self-citationInflammation and Cellular Immune Responses in Abdominal Aortic Aneurysms
Shimizu, K., Mitchell, R. N., & Libby, P. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000214999.12921.4f · Cited by 627
Metadata
- Authors
- Russell, R. E. K., Culpitt, S. V., DeMatos, C., Donnelly, L., Smith, M., Wiggins, J., & Barnes, P. J.
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-05-01
- Volume
- 26
- Issue
- 5
- Pages
- 602-609
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- OpenAlex
- W2023662838
- Cited by
- 448
- References
- 31
- FWCI
- 24.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.